Difference in the homocysteine-lowering effect of folic acid in haemodialysis patients with and without occlusive vascular disease

Nephrology Dialysis Transplantation

Volumn 16, Issue 3, 2001, Pages 585-589

  Descombes, Eric ^a   Boulat, Olivier ^b   Bersier, Louis Félix ^c   Fellay, Gilbert ^a  

^a Hopital Cantonal de Fribourg   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF NEUCHÂTEL   (Switzerland)

Author keywords

Cardiovascular disease; Folic acid; Haemodialysis; Homocysteine; Vitamins

Indexed keywords

ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CYANOCOBALAMIN; DIALVIT; EDETIC ACID; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMA PROTEIN; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TRIACYLGLYCEROL; VITAMIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BRAIN BLOOD VESSEL; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; MAINTENANCE THERAPY; MALE; NUTRITIONAL REQUIREMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLASMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 0035090493     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.3.585     Document Type: Article

References (24)

1. Homocysteine and atherosclerosis
2. Hyperhomocysteinemia in chronic renal disease
3. Folic acid, pyridoxine, cobalamin and homocysteine and their relationship to cardiovascular disease in end-stage renal disease
4. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations
5. Hyperhomocysteinemia in renal failure-what are the implications?
6. Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure
7. Hyperhomocysteinemia in hemodialysis patients, effects of 12-month supplementation with hydrosoluble vitamins
8. Major determinants of hyperhomocysteinemia in peritoneal dialysis patients
9. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure
10. Plasma homocysteine in renal failure
11. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease
12. Effect of the usual doses of folate supplementation on elevated plasma homocyst(e)ine in hemodialysis patients, no difference between 1 and 5 mg daily
13. Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients, is homocyst(e)ine the missing link?
14. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and in serum
15. Water soluble vitamins in hemodialysis patients and need for supplementation
16. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem
17. Homocysteine in health and disease
18. Vitamins B6, B12, and folate, association with plasma total homocysteine and risk of coronary atherosclerosis
19. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia
20. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease
21. Polymorphism in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid
22. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia, a double-blind, randomized, factorial-design, controlled trial
23. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients
24. The effect of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydro-folate reductase genotypes